Mediaiplus (CEO JiHee Jung) participated in SLUSH 2022, an event for startups held in Helsinki, Finland from November 17 (Thursday) to 18 (Friday).

Established in January 2019, Mediaiplus currently offers two services, FiCRO and MediC. FiCRO matches contract research organizations for clinical trials with clinical trial sponsors, such as pharmaceutical companies, whereas MediC provides a comprehensive overview of clinical trial results. Thanks to these two services, the startup was the only Korean company to make it to the finals of MassChallenge, and was selected as a participant in the “Public-Private Cooperation-Based Startup Project” by the Ministry of Science and Technology.

FiCRO, which the company showcased at SLUSH 2022, is a service designed to match contract research organizations (CROs) conducting clinical trials with clinical trial sponsors. According to Mediaiplus CEO JiHee Jung, “In the existing system, clinical trials require too much money and time, which is why we decided to develop this service. Our beta test revealed some optimistic results: an average of 75 days and up to 94% in time and expenses was saved.”

FiCRO searches for partners based on objective data and filters to find the CRO that can meet the needs of the client. In addition, Mediaiplus cited as its selling point reasonable pricing, which allows clients to conduct clinical trials in a more cost-effective manner compared to using existing expensive consulting and matching services. Furthermore, the service provides detailed, granular results that suit the client's needs based on a wider range of data.

“Our service is available to customers around the world. FiCRO is especially indispensable for CROs who are having a difficult time finding clients due to their lack of promotional channels. We are currently partnering with more than 50 non-clinical and clinical centers, university institutions, and overseas corporations as well as domestic companies. We anticipate that our expertise and knowledge can help address the bottleneck problem in the clinical trial industry and contribute to the acceleration of the vaccine development process,” CEO Jung said.

SLUSH is a renowned Northern European global startup exhibition, first held in 2008, where startups from all around the world meet major investors in Europe and Finland. The companies participating in SLUSH 2022 took part in promoting their companies by running the K-STARTUP Pavilion, the side event “K-STARTUP Demo Day,” and networking with professional investors using a matchmaking tool.

[Helsinki, Finland=AVING & Lecafedugeek Special Report Team – Joseph Choe, Dongkwan Kim, Mokkyung Lee, Leo Thevenet]